Rituxan (rituximab) - Roche
Sniffles to Hemodialysis: A Case of c-ANCA-Positive Vasculitis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0766; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He received HD (continued after discharge), plasmapheresis x5, methylprednisolone, and rituximab...As a result, the patient had a delay of several months between symptom onset and disease-specific treatment. Differentiating between infectious and autoimmune causes of upper respiratory symptoms can prove difficult; when symptoms progress despite treatment with empiric antibiotics, resistance and alternative diagnoses should be considered." 
Clinical • ANCA Vasculitis • Anorexia • Immunology • Infectious Disease • Nephrology • Ophthalmology • Renal Disease • Respiratory Diseases • Sinusitis • Vasculitis
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4554774
 
Jessee T. Tanasiuk; Minesh Rajpal
 
Oct 2, 2026
 
Prev Next